Pharmafile Logo
Pharmafocus logo
Advanced Search

Cancer

Showing 15 posts of 1067 posts found.

ASCObag

ASCO cancer conference opens

June 4, 2010
Research and Development ASCO, Cancer, lenalidomide, rituximab

One of the most important dates in the pharmaceutical industry’s calendar, the ASCO cancer conference begins today. The American Society …

News

Vaccine for brain cancer shows promise

June 3, 2010
Research and Development Cancer, GBM, ImmunoCellular

Early stage trials of a new treatment for the brain cancer glioblastoma multiforme have shown promise. ICT-107 is being developed …

News
Iressa

Asda cuts cancer drugs prices

May 24, 2010
Sales and Marketing Asda, Cancer, market access, price cuts, pricing, supermarket

UK supermarket chain Asda has started selling privately prescribed cancer drugs on a not-for-profit basis. The vast majority of drugs …

News

Boehringer signs antibody myeloma R&D deal

May 10, 2010
Research and Development Boehringer, Cancer, Micromet, myeloma

Boehringer Ingelheim and US biotech company Micromet are to research and develop a new BiTE antibody to treat multiple myeloma. …

News

Collaborative cancer drug project targets research efficiency

May 5, 2010
Research and Development Animal testing, Animal tests, Cancer, biomarkers, clinical drug development

A new pharma-academia project being managed by the University of Dundee is setting its sights on improving the effectiveness of …

News

Roche’s Xeloda widens licence

April 1, 2010
Sales and Marketing Cancer, Roche, Xeloda, colorectal cancer

Roche’s oral chemotherapy drug Xeloda has been approved in Europe in combination with intravenous oxaliplatin for the treatment of patients …

News

Cephalon to develop new class of cancer drug

March 19, 2010
Research and Development CRT, Cancer, Cancer Research UK, Cephalon

Pennsylvania-based Cephalon has signed a deal with the discovery arm of charity Cancer Research UK to develop a new class …

News

Roche delivers updated pipeline

March 18, 2010
Cancer, Roche

Roche says its pipeline can sustain its growth in oncology and increase its presence in personalised healthcare. Roche also plans …

News

Pfizer suffers late-stage cancer drug failures

March 12, 2010
Research and Development Cancer, Pfizer, Sutent, figitumumab

Pfizer has suffered late-stage trial failures for Sutent and lung cancer candidate figitumumab. Kidney cancer drug Sutent (sunitinib) failed to …

News

Recentin disappoints in colorectal cancer

March 9, 2010
Research and Development AZ, Cancer, Recentin, colorectal cancer

AstraZeneca’s developmental oncology drug Recentin has failed to meet its primary endpoint in a phase II/III study. The once-daily oral …

News

NHS funding boost for cancer diagnosis

March 8, 2010
Cancer, NHS, disease awareness campaigns

The government is to put £8 million into finding new ways of improving early cancer diagnosis for one or more …

News

Stability data issue holds up Adventrx cancer drug

March 3, 2010
Manufacturing and Production, Sales and Marketing Adventrx, Cancer, vinorelbine

US drugmaker Adventrx Pharmaceuticals has had the marketing application for its cancer drug ANX-530 (vinorelbine emulsion) rejected by the US …

News

Alimta recommended as maintenance therapy

March 1, 2010
Sales and Marketing Alimta, Cancer, NSCLC, lilly

 NICE has recommended Alimta as a maintenance treatment for people with locally advanced or metastatic non-small cell lung cancer. Patients …

News

Sanofi’s BSI-201 tipped for success in triple negative breast cancer

February 28, 2010
Sales and Marketing Cancer, PARP, Sanofi, breast cancer

 Sanofi-Aventis’s BSI-201 will garner sales of $1.7 billion in the triple negative breast cancer drug market in 2018, according to …

News

Avastin study in ovarian cancer meets primary endpoint

February 25, 2010
Research and Development Cancer, avastin, ovarian

Preliminary results from a trial of Roche’s Avastin in advanced ovarian cancer suggest that the drug lengthens progression-free survival when …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026